James R. Piper
About
In The Last Decade
James R. Piper
78 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 101
- Molecular Biology 666
- Organic Chemistry 516
- Infectious Diseases 229
- Epidemiology 193
- Oncology 159
Countries citing papers authored by James R. Piper
This map shows the geographic impact of James R. Piper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. Piper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. Piper more than expected).
Fields of papers citing papers by James R. Piper
This network shows the impact of papers produced by James R. Piper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. Piper. The network helps show where James R. Piper may publish in the future.
Co-authorship network of co-authors of James R. Piper
This figure shows the co-authorship network connecting the top 25 collaborators of James R. Piper. A scholar is included among the top collaborators of James R. Piper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James R. Piper. James R. Piper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 61 | |
| 2 | 12 | |
| 3 | 74 | |
| 4 | 50 | |
| 5 | Effective use of ribonucleotide reductase inhibitors (Didox and Trimidox) alone or in combination with didanosine (ddI) to suppress disease progression and increase survival in murine acquired immunodeficiency syndrome (MAIDS). | 12 |
| 6 | 8 | |
| 7 | 3 | |
| 8 | 28 | |
| 9 | 48 | |
| 10 | 8 | |
| 11 | 2 | |
| 12 | 5 | |
| 13 | 9 | |
| 14 | 17 | |
| 15 | 25 | |
| 16 | 15 | |
| 17 | Transport, growth inhibition and biochemical properties of the gamma-glutamyl and gamma-aspartyl peptides of 2,4-diamino folate analogs in l1210 leukemia cells in vitro. Abstr. | 2 |
| 18 | 5 | |
| 19 | 9 | |
| 20 | 10 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.